Better Defense Stock: Lockheed Martin vs. RTX

Governments are sharply increasing defense spending with $1.0 trillion allocated for 2026 and projections exceeding $1.5 trillion for 2027, driving sector-wide rearmament. Lockheed Martin reports a record backlog of $194 billion (more than 2.5x annual sales), 14% growth in missiles/fire control, and a framework to quadruple Precision Strike Missile production building on a prior $4.94 billion contract. RTX's backlog rose to $268 billion, with ~40% defense exposure, a $50 billion 20-year Patriot umbrella contract, and diversification via Pratt & Whitney (85,000 engines in service) and Collins Aerospace, giving it steadier commercial aftermarket cash flow. Analyst view favors RTX slightly for its diversified defense/commercial mix while Lockheed remains attractive for dividend-focused, pure-play defense exposure.

Analysis

The current rearmament impulse disproportionately rewards firms that can scale complex, low-volume production without blowing up margins. That creates a window where vertically integrated primes with in-house manufacturing and sustained aftermarket footprints can widen margins as smaller suppliers hit capacity and delivery slippage; expect short-term margin compression for thin-margin subcontractors and pricing power gains for tier‑1s that can absorb bottlenecks.

Fiscal timing is the dominant catalyst and the primary tail risk. Near-term share moves will be driven by appropriation calendars and discrete program funding votes (days–months), while true cash conversion from new awards plays out over multi-year program timelines. De‑escalation or a political pivot to deficit reduction could unwind much of the rerating quickly; conversely, execution beats on production ramp and aftermarket spare-part sales would compound returns over 12–36 months.

Consensus is underweight two second-order effects: working capital and capex strain during rapid scale-up, and asymmetric optionality from commercial aerospace exposure. The former pulls down free cash flow in year‑one of ramps even as revenue guidance improves; the latter means diversified primes can capture recovery upside in commercial OEM spares while keeping defense tail risk, making multi-year LEAP-style option structures attractive relative to outright equity ownership.

Key Decisions for Investors

• Pair trade — Long RTX / Short LMT (equal-dollar): 6–12 month horizon. Size each leg 2–3% NAV. Target: RTX to outperform LMT by 7–12% (capture diversification premium & commercial aftermarket rebound). Risk control: unwind if spread moves adverse by >8% or after key appropriation votes; rationale: hedge macro/defense funding beta while keeping idiosyncratic exposure to RTX commercial recovery.
• Tactical options — Long-dated RTX LEAPs (18–30 months, ~delta 0.30–0.45), size 1.5–2.5% NAV and finance with small sells of near-term calls (3–6 months): asymmetric payoff to multi-year backlog conversion and commercial aftermarket recovery. Downside = premium (loss limited); upside = high convexity if production ramps and spare sales accelerate.
• Income + risk mitigation on LMT — Buy shares and sell 3-month OTM calls (2–4% OTM) to harvest premium while collecting dividend; allocate 1.5–2.5% NAV. Use proceeds to finance a 6–12 month protective put (costly in stress; size 0.5–1% NAV) if political risk spikes. Expect modest quarterly yield uplift while capping large downside.
• Event hedge — Buy 6–12 month puts on LMT (small sizing 0.5–1% NAV) ahead of major appropriation votes or signing dates to protect against rapid de-escalation or budget re-prioritization. Cost is an insurance premium but preserves pair trades and LEAP optionality during binary headline risk.